Kaplan-Meier analysis of the survival for patients with ATL who responded to alemtuzumab therapy from Phase II Study of Alemtuzumab (CAMPATH-1) in Patients with HTLV-1–Associated Adult T-cell Leukemia/lymphoma

Autor:	John C. Morris, Thomas A. Waldmann, Seth M. Steinberg, Cathryn C. Lee, Thomas A. Fleisher, Mark Raffeld, Elaine S. Jaffe, Maryalice Stetler-Stevenson, Stefania Pittaluga, Donn Stewart, Deirdre O'Mahony, John E. Janik, Kamal Sharma
Rok vydání:	2023
DOI:	10.1158/1078-0432.22467129
Popis:	Kaplan-Meier analysis of the survival for patients with ATL who responded to alemtuzumab therapy
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8747d5d14eeaed03679515d841c40821 https://doi.org/10.1158/1078-0432.22467129 Zobrazit plný text záznamu